Miyakogusa Predicted Gene
- Lj4g3v2742900.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj4g3v2742900.1 Non Chatacterized Hit- tr|I1K4Y6|I1K4Y6_SOYBN
Uncharacterized protein OS=Glycine max PE=4 SV=1,86.46,0,seg,NULL;
Protein kinase-like (PK-like),Protein kinase-like domain;
Phosphoinositide 3-kinase,
catal,NODE_631_length_1702_cov_127.557579.path2.1
(471 letters)
Database: TAIR10_pep
35,386 sequences; 14,482,855 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
AT5G64070.1 | Symbols: PI-4KBETA1, PI4KBETA1 | phosphatidylinosi... 745 0.0
AT5G09350.1 | Symbols: PI-4KBETA2, PI4KBETA2 | phosphatidylinosi... 733 0.0
AT1G49340.1 | Symbols: ATPI4K ALPHA | Phosphatidylinositol 3- an... 176 5e-44
AT1G49340.2 | Symbols: ATPI4K ALPHA | Phosphatidylinositol 3- an... 176 5e-44
AT1G51040.1 | Symbols: | Protein kinase superfamily protein | c... 159 4e-39
AT1G60490.1 | Symbols: ATVPS34, VPS34, PI3K | vacuolar protein s... 111 1e-24
AT1G50030.1 | Symbols: TOR | target of rapamycin | chr1:18522626... 55 1e-07
AT1G50030.2 | Symbols: TOR | target of rapamycin | chr1:18522626... 55 1e-07
AT3G48190.1 | Symbols: ATM, ATATM | ataxia-telangiectasia mutate... 52 7e-07
>AT5G64070.1 | Symbols: PI-4KBETA1, PI4KBETA1 | phosphatidylinositol
4-OH kinase beta1 | chr5:25637492-25643902 REVERSE
LENGTH=1121
Length = 1121
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/471 (78%), Positives = 395/471 (83%), Gaps = 5/471 (1%)
Query: 1 MYRVLHIPEDEAVLLNSREKAPYMICTEVLRCEMPSNPKETSSSQKLSQGGIPLANGDAL 60
++RV+HIPEDE +LLNSREKAPYMI EVL+ E PS KE+S+SQKLS+GGIPLANGDA
Sbjct: 609 VFRVVHIPEDECILLNSREKAPYMISVEVLKAETPS-AKESSNSQKLSKGGIPLANGDAF 667
Query: 61 LHKPPPWAYPLSTAQEVYRNSNDRMSRSTAQAIDQAMTHVSETKVKFVSLHLSVETQING 120
L KPPPWAYPL T QEVYRNS DRMS STAQAIDQAMT SE KVK V++ LSVE + +
Sbjct: 668 LQKPPPWAYPLWTTQEVYRNSADRMSLSTAQAIDQAMTPKSEVKVKLVNVSLSVEDRTSA 727
Query: 121 QSGKTGVADLCNGSRHPASIYREDWNDLEWVRVVLTADPGVRMEDIEDQAPRRKKEHRRV 180
D G + NDLEWVRVV+TADPG+RME I D + RKKEHRRV
Sbjct: 728 LESFGDPIDDVLGEAPRTGLN----NDLEWVRVVVTADPGLRMESIPDPSVPRKKEHRRV 783
Query: 181 PSXXXXXXXXXXXXXGEAPIGLPLKGAGQDSSETQPKANGITPRASDALSGELWEAKKDR 240
PS GEAP GLPLKGAGQDSS+ QP+ANG + DALSGELWE K+DR
Sbjct: 784 PSTVAMEEVRAAAAKGEAPPGLPLKGAGQDSSDAQPRANGGMLKEGDALSGELWEGKRDR 843
Query: 241 ICKASIYGKLPGWDLRSVIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLCT 300
I KASIYGKLPGWDLRS+IVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVL T
Sbjct: 844 IRKASIYGKLPGWDLRSIIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLVT 903
Query: 301 SSYTALIETIPDTASLHSIKSRYPNISSLREFFNAKYEENSPSFKLAQRNFVESMAGYSL 360
SSYTALIETIPDTAS+HSIKSRYPNI+SLR+FF AKY+ENSPSFKLAQRNFVESMAGYSL
Sbjct: 904 SSYTALIETIPDTASIHSIKSRYPNITSLRDFFVAKYKENSPSFKLAQRNFVESMAGYSL 963
Query: 361 VCYFLQVKDRHNGNLLLDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEVMDSDA 420
VCY LQVKDRHNGNLLLDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEVMDSDA
Sbjct: 964 VCYLLQVKDRHNGNLLLDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEVMDSDA 1023
Query: 421 EGVPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDSDFPCFNGGTRTI 471
+GVPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDS FPCF GG RTI
Sbjct: 1024 DGVPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDSGFPCFKGGPRTI 1074
>AT5G09350.1 | Symbols: PI-4KBETA2, PI4KBETA2 | phosphatidylinositol
4-OH kinase beta2 | chr5:2899365-2905610 REVERSE
LENGTH=1116
Length = 1116
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/476 (76%), Positives = 392/476 (82%), Gaps = 19/476 (3%)
Query: 1 MYRVLHIPEDEAVLLNSREKAPYMICTEVLRCEMPSNPKETSSSQKLSQGGIPLANGDAL 60
+YRV++IPEDE VLLNSREK PYMIC EVL+ E P K TS+S KLS+GGIPLANGDA
Sbjct: 608 VYRVVNIPEDEYVLLNSREKVPYMICVEVLKAETPCGAKTTSTSLKLSKGGIPLANGDAF 667
Query: 61 LHKPPPWAYPLSTAQEVYRNSNDRMSRSTAQAIDQAMTHVSETKVKFVSLHLSVETQING 120
LHKPPPWAYPLSTAQEVYRNS DRMS ST +AIDQAMTH SE VK V+ LSVET N
Sbjct: 668 LHKPPPWAYPLSTAQEVYRNSADRMSLSTVEAIDQAMTHKSE--VKLVNACLSVETHSNS 725
Query: 121 Q-----SGKTGVADLCNGSRHPASIYREDWNDLEWVRVVLTADPGVRMEDIEDQAPRRKK 175
SG TGV L G +DLEWVR+VLTADPG+RME I D R+K
Sbjct: 726 NTKSVSSGVTGV--LRTGLE----------SDLEWVRLVLTADPGLRMESITDPKTPRRK 773
Query: 176 EHRRVPSXXXXXXXXXXXXXGEAPIGLPLKGAGQDSSETQPKANGITPRASDALSGELWE 235
EHRRV S GEAP GLPLKGAGQDSS+ QP ANG +A DALSGE WE
Sbjct: 774 EHRRVSSIVAYEEVRAAAAKGEAPPGLPLKGAGQDSSDAQPMANGGMLKAGDALSGEFWE 833
Query: 236 AKKDRICKASIYGKLPGWDLRSVIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPY 295
K+ RI K SIYG LPGWDLRS+IVKSGDDCRQEHLAVQLISHF+DIFQEAGLPLWLRPY
Sbjct: 834 GKRLRIRKDSIYGNLPGWDLRSIIVKSGDDCRQEHLAVQLISHFFDIFQEAGLPLWLRPY 893
Query: 296 EVLCTSSYTALIETIPDTASLHSIKSRYPNISSLREFFNAKYEENSPSFKLAQRNFVESM 355
EVL TSSYTALIETIPDTAS+HSIKSRYPNI+SLR+FF+AK++ENSPSFKLAQRNFVESM
Sbjct: 894 EVLVTSSYTALIETIPDTASIHSIKSRYPNITSLRDFFDAKFKENSPSFKLAQRNFVESM 953
Query: 356 AGYSLVCYFLQVKDRHNGNLLLDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEV 415
AGYSLVCY LQ+KDRHNGNLL+DEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEV
Sbjct: 954 AGYSLVCYLLQIKDRHNGNLLMDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEV 1013
Query: 416 MDSDAEGVPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDSDFPCFNGGTRTI 471
MDSDAEG+PSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDS FPCF GG RTI
Sbjct: 1014 MDSDAEGLPSEFFDYFKVLCIQGFLTCRKHAERIILLVEMLQDSGFPCFKGGPRTI 1069
>AT1G49340.1 | Symbols: ATPI4K ALPHA | Phosphatidylinositol 3- and
4-kinase family protein | chr1:18252355-18263967 FORWARD
LENGTH=2028
Length = 2028
Score = 176 bits (445), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 94/214 (43%), Positives = 133/214 (62%), Gaps = 5/214 (2%)
Query: 256 RSVIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLCTSSYTALIETIPDTAS 315
++ I K GDDCRQ+ LA+Q+IS DIFQ AGL L+L PY VL T + +IE +P+T S
Sbjct: 1767 QACIFKVGDDCRQDVLALQVISLLRDIFQAAGLNLYLFPYGVLPTGAERGIIEVVPNTRS 1826
Query: 316 LHSIKSRYPNISSLREFFNAKYEE-NSPSFKLAQRNFVESMAGYSLVCYFLQVKDRHNGN 374
+ L E F Y S +F+ A+ NF+ S AGY++ LQ KDRHNGN
Sbjct: 1827 RSQMGETTDG--GLYEIFQQDYGPVGSTTFETARENFLISSAGYAVASLLLQPKDRHNGN 1884
Query: 375 LLLDEEGHIIHIDFGFMLSNSPGG-VNFESAPFKLTRELLEVMDSDAEGVPSEFFDYFKV 433
LL D+ G ++HIDFGF+L SPGG + FESA FKL+ E+ +++D + S+ + F
Sbjct: 1885 LLFDDVGRLVHIDFGFILETSPGGNMRFESAHFKLSHEMTQLLDPSGV-MKSKTWHQFVS 1943
Query: 434 LCIQGFLTCRKHAERIILLVEMLQDSDFPCFNGG 467
LC++G+L R+ + II V+M+ +S PCF+ G
Sbjct: 1944 LCVKGYLAARRQMDGIISTVQMMLESGLPCFSRG 1977
>AT1G49340.2 | Symbols: ATPI4K ALPHA | Phosphatidylinositol 3- and
4-kinase family protein | chr1:18252355-18263967 FORWARD
LENGTH=2028
Length = 2028
Score = 176 bits (445), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 94/214 (43%), Positives = 133/214 (62%), Gaps = 5/214 (2%)
Query: 256 RSVIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLCTSSYTALIETIPDTAS 315
++ I K GDDCRQ+ LA+Q+IS DIFQ AGL L+L PY VL T + +IE +P+T S
Sbjct: 1767 QACIFKVGDDCRQDVLALQVISLLRDIFQAAGLNLYLFPYGVLPTGAERGIIEVVPNTRS 1826
Query: 316 LHSIKSRYPNISSLREFFNAKYEE-NSPSFKLAQRNFVESMAGYSLVCYFLQVKDRHNGN 374
+ L E F Y S +F+ A+ NF+ S AGY++ LQ KDRHNGN
Sbjct: 1827 RSQMGETTDG--GLYEIFQQDYGPVGSTTFETARENFLISSAGYAVASLLLQPKDRHNGN 1884
Query: 375 LLLDEEGHIIHIDFGFMLSNSPGG-VNFESAPFKLTRELLEVMDSDAEGVPSEFFDYFKV 433
LL D+ G ++HIDFGF+L SPGG + FESA FKL+ E+ +++D + S+ + F
Sbjct: 1885 LLFDDVGRLVHIDFGFILETSPGGNMRFESAHFKLSHEMTQLLDPSGV-MKSKTWHQFVS 1943
Query: 434 LCIQGFLTCRKHAERIILLVEMLQDSDFPCFNGG 467
LC++G+L R+ + II V+M+ +S PCF+ G
Sbjct: 1944 LCVKGYLAARRQMDGIISTVQMMLESGLPCFSRG 1977
>AT1G51040.1 | Symbols: | Protein kinase superfamily protein |
chr1:18920658-18923314 FORWARD LENGTH=525
Length = 525
Score = 159 bits (402), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 90/214 (42%), Positives = 129/214 (60%), Gaps = 13/214 (6%)
Query: 256 RSVIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLCTSSYTALIETIPDTAS 315
++ I K GDDCRQ+ LA+Q+IS DIFQ GL L+L PY VL T +P+T S
Sbjct: 272 QACIFKVGDDCRQDVLALQVISLLGDIFQAVGLNLYLFPYGVLPT--------VVPNTRS 323
Query: 316 LHSIKSRYPNISSLREFFNAKYE-ENSPSFKLAQRNFVESMAGYSLVCYFLQVKDRHNGN 374
+ L E F Y S +F+ A+ NF+ S AGY++ LQ KDRHNGN
Sbjct: 324 RSQMGETTDG--GLYEIFQQNYGLVGSTTFETARANFLISSAGYAVASLLLQPKDRHNGN 381
Query: 375 LLLDEEGHIIHIDFGFMLSNSPGG-VNFESAPFKLTRELLEVMDSDAEGVPSEFFDYFKV 433
LL D+ G ++HIDFGF+L SPGG + FE+A FKL+ E+ +++D + S+ + F
Sbjct: 382 LLFDDVGRLVHIDFGFILETSPGGNMRFENAHFKLSHEMTQLLDPSGV-MKSKTWHQFVS 440
Query: 434 LCIQGFLTCRKHAERIILLVEMLQDSDFPCFNGG 467
LC++G+L R++ + II V+M+ +S PCF+ G
Sbjct: 441 LCVKGYLAARRYMDEIISTVQMMLESGLPCFSRG 474
>AT1G60490.1 | Symbols: ATVPS34, VPS34, PI3K | vacuolar protein
sorting 34 | chr1:22285792-22290190 REVERSE LENGTH=814
Length = 814
Score = 111 bits (278), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 258 VIVKSGDDCRQEHLAVQLISHFYDIFQEAGLPLWLRPYEVLCTSSYTALIETIPDTASLH 317
+I K GDD RQ+ L VQ++ + + L L L PY+VL T ++E IP + SL
Sbjct: 561 LIFKKGDDLRQDQLVVQMVWLMDRLLKLENLDLCLTPYKVLATGHDEGMLEFIP-SRSLA 619
Query: 318 SIKSRYPNISSLREFFNAKYEENSPSFKLAQ--RNFVESMAGYSLVCYFLQVKDRHNGNL 375
I S + +I+S + F+ +E++P A F++S AGYS++ Y L + DRH NL
Sbjct: 620 QILSEHRSITSYLQKFHP--DEHAPFGITATCLDTFIKSCAGYSVITYILGIGDRHLDNL 677
Query: 376 LLDEEGHIIHIDFGFMLSNSPGGVNFESAPFKLTRELLEVMDSDAEGVPSEFFDYFKVLC 435
LL ++G + H+DF F+L P P KL +E++E M G S+++ FK C
Sbjct: 678 LLTDDGRLFHVDFAFILGRDPKPF---PPPMKLCKEMVEAMG----GAESQYYTRFKSYC 730
Query: 436 IQGFLTCRKHAERIILLVEMLQDSDFP 462
+ + RK + I+ L ++ S P
Sbjct: 731 CEAYNILRKSSNLILNLFHLMAGSTIP 757
>AT1G50030.1 | Symbols: TOR | target of rapamycin |
chr1:18522626-18539619 REVERSE LENGTH=2481
Length = 2481
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 55/263 (20%)
Query: 238 KDRICKASIYGKLPGWDLRSVIVKSGDDCRQEHLAVQLISHFYDIFQE----AGLPLWLR 293
K R K +I+G G D + ++K +D RQ+ +QL + + A L ++
Sbjct: 2075 KQRPRKLTIHGN-DGEDY-AFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEKDLSIQ 2132
Query: 294 PYEVLCTSSYTALIETIPDTASLH----------------------SIKSRYPNISSLRE 331
Y V+ S + LI +P+ +LH S Y N+ + +
Sbjct: 2133 RYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNLPLIAK 2192
Query: 332 FFNAKYE-ENSPSFKLAQ----------------RNFVESMAGYSLVCYFLQVKDRHNGN 374
+Y EN+ L++ N+ S+A S+V Y L + DRH N
Sbjct: 2193 VEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGDRHPSN 2252
Query: 375 LLLDE-EGHIIHIDFGFMLSNSPGGVNF-ESAPFKLTRELLEVMD-SDAEGVPSEFFDYF 431
L+L G I+HIDFG S F E PF+LTR L++ M+ S EG F
Sbjct: 2253 LMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEG-------NF 2305
Query: 432 KVLCIQGFLTCRKHAERIILLVE 454
+ C R + + ++ ++E
Sbjct: 2306 RSTCENVMQVLRTNKDSVMAMME 2328
>AT1G50030.2 | Symbols: TOR | target of rapamycin |
chr1:18522626-18539619 REVERSE LENGTH=2454
Length = 2454
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 55/263 (20%)
Query: 238 KDRICKASIYGKLPGWDLRSVIVKSGDDCRQEHLAVQLISHFYDIFQE----AGLPLWLR 293
K R K +I+G G D + ++K +D RQ+ +QL + + A L ++
Sbjct: 2048 KQRPRKLTIHGN-DGEDY-AFLLKGHEDLRQDERVMQLFGLVNTLLENSRKTAEKDLSIQ 2105
Query: 294 PYEVLCTSSYTALIETIPDTASLH----------------------SIKSRYPNISSLRE 331
Y V+ S + LI +P+ +LH S Y N+ + +
Sbjct: 2106 RYSVIPLSPNSGLIGWVPNCDTLHHLIREHRDARKIILNQENKHMLSFAPDYDNLPLIAK 2165
Query: 332 FFNAKYE-ENSPSFKLAQ----------------RNFVESMAGYSLVCYFLQVKDRHNGN 374
+Y EN+ L++ N+ S+A S+V Y L + DRH N
Sbjct: 2166 VEVFEYALENTEGNDLSRVLWLKSRSSEVWLERRTNYTRSLAVMSMVGYILGLGDRHPSN 2225
Query: 375 LLLDE-EGHIIHIDFGFMLSNSPGGVNF-ESAPFKLTRELLEVMD-SDAEGVPSEFFDYF 431
L+L G I+HIDFG S F E PF+LTR L++ M+ S EG F
Sbjct: 2226 LMLHRYSGKILHIDFGDCFEASMNREKFPEKVPFRLTRMLVKAMEVSGIEG-------NF 2278
Query: 432 KVLCIQGFLTCRKHAERIILLVE 454
+ C R + + ++ ++E
Sbjct: 2279 RSTCENVMQVLRTNKDSVMAMME 2301
>AT3G48190.1 | Symbols: ATM, ATATM | ataxia-telangiectasia mutated |
chr3:17797628-17828361 FORWARD LENGTH=3845
Length = 3845
Score = 52.4 bits (124), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 332 FFNAKYEENSPSFKLAQRNFVESMAGYSLVCYFLQVKDRHNGNLLLDE-EGHIIHIDFGF 390
FF K+ + + F + + + S+A S+V Y + + DRH N+L+D+ ++HID G
Sbjct: 3634 FFLEKFLQPADWF-VKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGV 3692
Query: 391 MLSNSPGGVNFESAPFKLTRELLEVMD-SDAEGVPSEFFDYFKVLCIQGFLTCRKHAERI 449
E PF+LTR++++ M + EGV F+ C + R + E +
Sbjct: 3693 AFEQGLMLKTPERVPFRLTRDIIDGMGITGVEGV-------FRRCCEETLSVMRTNKEAL 3745
Query: 450 ILLVEML 456
+ +VE+
Sbjct: 3746 LTIVEVF 3752